Search Results - "ZOCCOLELLA, S"

Refine Results
  1. 1

    Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics by Milella, G, Introna, A, Mezzapesa, D M, D'Errico, E, Fraddosio, A, Ucci, M, Zoccolella, S, Simone, I L

    Published in American journal of neuroradiology : AJNR (01-04-2023)
    “…The previous studies described phenotype-associated imaging findings in amyotrophic lateral sclerosis (ALS) with a prior categorization of patients based on…”
    Get full text
    Journal Article
  2. 2

    Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression by Tortelli, R., Ruggieri, M., Cortese, R., D'Errico, E., Capozzo, R., Leo, A., Mastrapasqua, M., Zoccolella, S., Leante, R., Livrea, P., Logroscino, G., Simone, I. L.

    Published in European journal of neurology (01-12-2012)
    “…Background To date there are no biomarkers with proven reliability as a measure of disease burden in amyotrophic lateral sclerosis (ALS). The aim of our study…”
    Get full text
    Journal Article
  3. 3

    A 71‐nucleotide deletion in the periaxin gene in an Italian patient with late‐onset slowly progressive demyelinating Charcot‐Marie‐Tooth disease by Citrigno, L., Zoccolella, S., Lastella, P., Simone, I. L., Muglia, M.

    Published in European journal of neurology (01-10-2020)
    “…Background Charcot‐Marie‐Tooth disease (CMT) constitutes a group of heterogeneous hereditary motor and sensor neuropathies. Mutations in the periaxin (PRX)…”
    Get full text
    Journal Article
  4. 4

    Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis by Tortelli, R., Copetti, M., Ruggieri, M., Cortese, R., Capozzo, R., Leo, A., D'Errico, E., Mastrapasqua, M., Zoccolella, S., Pellegrini, F., Simone, I. L., Logroscino, G.

    Published in European journal of neurology (01-01-2015)
    “…Background and purpose To evaluate whether cerebrospinal fluid (CSF) neurofilament light chain (NFL) levels could predict the time to generalization (TTG) in…”
    Get full text
    Journal Article
  5. 5

    Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study by Zoccolella, S, Beghi, E, Palagano, G, Fraddosio, A, Guerra, V, Samarelli, V, Lepore, V, Simone, I L, Lamberti, P, Serlenga, L, Logroscino, G

    “…Objective:To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS).Methods:Incident cases, diagnosed in the 1998–1999 period…”
    Get full text
    Journal Article
  6. 6

    Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients by Paolicelli, D, Manni, A, D ' Onghia, M, Direnzo, V, Iaffaldano, P, Zoccolella, S, Di Lecce, V, Tortorella, C, Specchia, G, Trojano, M

    Published in Journal of neuroimmunology (15-02-2017)
    “…Abstract We investigated, lymphocyte count (LC) and lymphocyte subsets (LS ) in a real life setting of Fingolimod (FTY) treated Relapsing MS (RMS) patients …”
    Get full text
    Journal Article
  7. 7

    Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study by Tortelli, R., Copetti, M., Panza, F., Fontana, A., Cortese, R., Capozzo, R., Introna, A., D'Errico, E., Zoccolella, S., Arcuti, S., Seripa, D., Simone, I. L., Logroscino, G.

    Published in European journal of neurology (01-06-2016)
    “…Background and purpose A strong association between time to generalization (TTG), considered as the time of spreading of the clinical signs from spinal or…”
    Get full text
    Journal Article
  8. 8

    Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry by Pupillo, E., Messina, P., Logroscino, G., Zoccolella, S., Chiò, A., Calvo, A., Corbo, M., Lunetta, C., Micheli, A., Millul, A., Vitelli, E., Beghi, E.

    Published in European journal of neurology (01-12-2012)
    “…Background and purpose Published reports on the association between amyotrophic lateral sclerosis (ALS) and trauma are controversial suggesting the need for a…”
    Get full text
    Journal Article
  9. 9

    Elevated homocysteine levels in Parkinson's Disease: is there anything besides L-dopa treatment? by Zoccolella, S, dell'Aquila, C, Specchio, L M, Logroscino, G, Lamberti, P

    Published in Current medicinal chemistry (2010)
    “…Homocysteine (Hcy) exerts multiple neurotoxic mechanisms that have been linked to the pathogenesis of neurodegenerative disorders. Several studies observed…”
    Get more information
    Journal Article
  10. 10

    Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis by ZOCCOLELLA, S, SIMONE, I. L, LAMBERTI, P, SAMARELLI, V, TORTELLI, R, SERLENGA, L, LOGROSCINO, G

    Published in Neurology (15-01-2008)
    “…Both in vitro and in vivo studies indicate that homocysteine (Hcy) may be directly involved in the damage of motor neurons and in several pathways implicated…”
    Get full text
    Journal Article
  11. 11

    Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study by Logroscino, G, Beghi, E, Zoccolella, S, Palagano, R, Fraddosio, A, Simone, I L, Lamberti, P, Lepore, V, Serlenga, L

    “…Background: While the incidence of amyotrophic lateral sclerosis (ALS) is similar across the world (range, 1.0 to 2.5/100 000), a latitude gradient from north…”
    Get full text
    Journal Article
  12. 12

    Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy by Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Guerra, V., Samarelli, V., Lepore, V., Simone, I. L., Lamberti, P., Serlenga, L., Logroscino, G.

    Published in European journal of neurology (01-03-2007)
    “…Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (ALS) survival. However, results on the efficacy of riluzole in…”
    Get full text
    Journal Article
  13. 13

    Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis by Tortorella, C, Direnzo, V, Taurisano, P, Romano, R, Ruggieri, M, Zoccolella, S, Mastrapasqua, M, Popolizio, T, Blasi, G, Bertolino, A, Trojano, M

    Published in Multiple sclerosis (01-04-2015)
    “…Background: Identifying markers of cognitive dysfunction in multiple sclerosis (MS) is extremely challenging since it means supplying potential biomarkers for…”
    Get full text
    Journal Article
  14. 14

    Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? by Zoccolella, S, Lamberti, S V, Iliceto, G, Santamato, A, Lamberti, P, Logroscino, G

    Published in Current medicinal chemistry (01-09-2010)
    “…Hyperhomocysteinemia has been associated with cognitive dysfunction and dementia. The incidence of dementia in Parkinson's Disease (PD) patients is higher than…”
    Get more information
    Journal Article
  15. 15

    Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis by Tortorella, C, Romano, R, Direnzo, V, Taurisano, P, Zoccolella, S, Iaffaldano, P, Fazio, L, Viterbo, R, Popolizio, T, Blasi, G, Bertolino, A, Trojano, M

    Published in Multiple sclerosis (01-08-2013)
    “…Background: Load-related functional magnetic resonance imaging (fMRI) abnormalities of brain activity during performance of attention tasks have been described…”
    Get full text
    Journal Article
  16. 16

    72. Electromiography as useful test in the differential diagnosis of neuromuscular diseases only after clinical examination by Bellomo, R, Zoccolella, S, Lapenna, F, Lecce, B, Cologna, D, Mazzeo, A, Pellicciari, R

    Published in Clinical neurophysiology (01-11-2013)
    “…Electromiography (EMG) plays a key role in the evaluation of patients with neuromuscular diseases. It can be considered an extension of the neurological…”
    Get full text
    Journal Article
  17. 17

    The incidence of major stroke subtypes in Southern Italy: a population-based study by Manobianca, G., Zoccolella, S., Petruzzellis, A., Miccoli, A., Logroscino, G.

    Published in European journal of neurology (01-09-2010)
    “…Background and purpose:  Stroke is characterized by well‐defined clinical major subtypes, but there are few studies on incidence rates, aetiologies and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy by Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Samarelli, V., Lamberti, P., Lepore, V., Serlenga, L., Logroscino, G.

    Published in European journal of neurology (01-07-2006)
    “…Amyotrophic lateral sclerosis (ALS) diagnostic criteria are used to select patients for clinical trials based on different levels of diagnostic certainty,…”
    Get full text
    Journal Article